Vitamin D and the Influenza Epidemic
NCT01182870 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 569
Last updated 2011-07-20
Summary
Subjects included in ongoing vitamin d intervention trials were asked by questionnaire if they were ill with influenza during the winter season 2009/2010 to see if vitamin d supplementation prevented flu like disease.
Conditions
Interventions
- DRUG
-
choleclaciferol
800-6000 IU cholecalciferol per day
Sponsors & Collaborators
-
University of Tromso
lead OTHER
Principal Investigators
-
rolf Jorde, md · University of Tromso, Norway
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2010-09-30
- Completion
- 2010-10-31
Countries
- Norway
Study Locations
More Related Trials
-
A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections
NCT01158560 ·Status: COMPLETED ·Phase: PHASE3
-
A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Status in Healthy Adults
NCT01924910 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children
NCT02649192 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial of Vitamin D3 Supplementation for Viral Upper Respiratory Tract Infections (URI) Prevention
NCT00656929 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection
NCT04636086 ·Status: COMPLETED ·Phase: PHASE4
-
Short Term, High Dose Vitamin D Supplementation for COVID-19
NCT04459247 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D on Morbidity and Mortality of the COVID-19
NCT04552951 ·Status: UNKNOWN ·Phase: PHASE4
-
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
NCT04482673 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Vitamin D Supplementation for the Prevention of Acute Respiratory Infections: a RCT in Young Finnish Men
NCT05014048 ·Status: COMPLETED ·Phase: NA
-
Cholecalciferol to Improve the Outcomes of COVID-19 Patients
NCT04411446 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection
NCT04368520 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Vitamin D Supplementation on Muscular Strength, Musculoskeletal Pain and Headache
NCT01263288 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers
NCT04535791 ·Status: COMPLETED ·Phase: PHASE3
-
Tele-health Enabled Clinical Trial for COVID-19
NCT04489628 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
NCT04810949 ·Status: TERMINATED ·Phase: NA
-
Cholecalciferol Intervention to Prevent Respiratory Infections Study
NCT01549938 ·Status: COMPLETED ·Phase: PHASE2
-
The GLOBAL Vitamin D Study. A Genomic, Transcriptomic, Proteomic and Metabolomic Approach
NCT02783924 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin D and Staphylococcus Aureus in the Diabetes Study
NCT01395290 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors
NCT02750293 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Vitamin D Supplementation on Antimycobacterial Immunity
NCT00157066 ·Status: COMPLETED ·Phase: NA
-
Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease
NCT04952857 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D for the Prevention of Diabetes Type 2
NCT00685594 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children
NCT02046577 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Vitamin D Supplementation on Host Immunity to Mycobacterium Tuberculosis and Response to Treatment
NCT00918086 ·Status: COMPLETED ·Phase: PHASE2
-
Severity of COVID-19 and Vitamin D Supplementation
NCT05166005 ·Status: UNKNOWN ·Phase: PHASE4